Work

Real-world trends of PARPi maintenance treatment uptake and progression-free survival (PFS) in patients (pts) with newly diagnosed advanced ovarian cancer (AOC) in the United States.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.6580

Authors: John K Chan, Jinan Liu, Jinlin Song, Cheryl Xiang, Eric Q. Wu, Linda Kalilani, Jean Hurteau, Premal H. Thaker

Institutions: Palo Alto Medical Foundation, GlaxoSmithKline (United States), Analysis Group (United States), Washington University in St. Louis

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4281716201

Cites:

Cited by: 3

Related to: 10